Publications by authors named "Larry Yet"

Claim this Profile
M
Multi-Substituted Quinolines as HIV-1 Integrase Allosteric Inhibitors.
Long Phi Dinh, Jian Sun, Courtney D Glenn, Krunal Patel, Julie A Pigza, Larry Yet

Viruses· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of 3-aryl-1-phosphinoimidazo[1,5-]pyridine ligands for use in Suzuki-Miyaura cross-coupling reactions.
Ryan Q Tran, Long P Dinh, Seth A Jacoby, Nekoda W Harris, William A Swann, Larry Yet

RSC Adv· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of 3-aryl-2-phosphinoimidazo[1,2-]pyridine ligands for use in palladium-catalyzed cross-coupling reactions.
Ryan Q Tran, Seth A Jacoby, Kaitlyn E Roberts, William A Swann, Nekoda W Harris, Larry Yet

RSC Adv· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphodiesterase 10A is overexpressed in lung tumor cells and inhibitors selectively suppress growth by blocking β-catenin and MAPK signaling.
Bing Zhu, Ashley Lindsey, Nan Li, Kevin Lee, Veronica Ramirez-Alcantara, Larry Yet

Oncotarget· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crystal structures and mutagenesis of PPP-family ser/thr protein phosphatases elucidate the selectivity of cantharidin and novel norcantharidin-based inhibitors of PP5C.
Debasish Chattopadhyay, Mark R Swingle, Edward A Salter, Eric Wood, Brandon D'Arcy, Larry Yet

Biochem Pharmacol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progress in the development of fatty acid synthase inhibitors as anticancer targets.
Genevieve E Mullen, Larry Yet

Bioorg Med Chem Lett· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial optimization and series evolution of diaminopyrimidine inhibitors of interleukin-1 receptor associated kinase 4.
W Michael Seganish, William T McElroy, R Jason Herr, Stephanie Brumfield, William J Greenlee, Larry Yet

Bioorg Med Chem Lett· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and hit-to-lead optimization of 2,6-diaminopyrimidine inhibitors of interleukin-1 receptor-associated kinase 4.
William T McElroy, W Michael Seganish, R Jason Herr, James Harding, Jinhai Yang, Larry Yet

Bioorg Med Chem Lett· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of 4-heteroaryl 1,2,3,4-tetrahydroisoquinolines as triple reuptake inhibitors.
Shuang Liu, Congxiang Zha, Kassoum Nacro, Min Hu, Wenge Cui, Larry Yet

ACS Med Chem Lett· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and SAR of heterocyclic carboxylic acid isosteres based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesity.
Mark Hadden, Allan Goodman, Cheng Guo, Peter R Guzzo, Alan J Henderson, Larry Yet

Bioorg Med Chem Lett· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of 7-benzyl-5-(piperidin-1-yl)-6,7,8,9-tetrahydro-3H-pyrazolo[3,4-c][2,7]naphthyridin-1-ylamine and its analogs as bombesin receptor subtype-3 agonists.
Cheng Guo, Peter R Guzzo, Mark Hadden, Bruce J Sargent, Larry Yet

Bioorg Med Chem Lett· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and SAR of derivatives based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesity.
Jian Liu, Shuwen He, Tianying Jian, Peter H Dobbelaar, Iyassu K Sebhat, Larry Yet

Bioorg Med Chem Lett· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of substituted biphenyl imidazoles as potent, bioavailable bombesin receptor subtype-3 agonists.
Shuwen He, Peter H Dobbelaar, Jian Liu, Tianying Jian, Iyassu K Sebhat, Larry Yet

Bioorg Med Chem Lett· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemistry and biology of salicylihalamide a and related compounds.
Larry Yet

Chem Rev· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent Developments in Catalytic Asymmetric Strecker-Type Reactions.
Larry Yet

Angew Chem Int Ed Engl· March 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis